Engle Capital Management’s Teladoc Health TDOC Stock Holding History

Engle Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,000	Closed	-$3.39M	–	22
2019 Q3	$3.39M	Sell	50,000 -7,000	-12%	-$461K	0.9%	17
2019 Q2	$3.79M	Sell	57,000 -135,000	-70%	-$7.87M	0.9%	19
2019 Q1	$10.7M	Buy	+192,000	New	+$11.7M	2.78%	14
2018 Q4	–	Sell	-131,000	Closed	-$11.3M	–	24
2018 Q3	$11.3M	Sell	131,000 -19,000	-13%	-$1.35M	3.75%	12
2018 Q2	$8.71M	Buy	150,000 +70,000	+88%	+$3.42M	3.83%	13
2018 Q1	$3.22M	Buy	80,000 +4,000	+5%	+$151K	1.59%	18
2017 Q4	$2.65M	Sell	76,000 -45,000	-37%	-$1.49M	1.36%	22
2017 Q3	$4.01M	Buy	121,000 +53,200	+78%	+$1.74M	1.93%	19
2017 Q2	$2.35M	Buy	+67,800	New	+$1.98M	1.44%	18

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Engle Capital Management's TDOC Position: Q4 2019 in Review

Engle Capital Management sold out of Teladoc Health (TDOC) in Q4 2019, closing a stake of 50,000 shares — an estimated $3.39M sold.

Engle Capital Management first reported a position in TDOC in Q2 2017 and held it in 9 quarters. The position peaked at $11.3M in Q3 2018. 420 funds tracked by Wall St. Rank hold TDOC as of Q4 2019.

Engle Capital Management reported no remaining Teladoc Health position as of Q4 2019 after selling out during the quarter.
Engle Capital Management sold 50,000 Teladoc Health shares in Q4 2019, an estimated $3.39M.
Engle Capital Management first reported a position in Teladoc Health in Q2 2017 and held it in 9 quarters.
Engle Capital Management's Teladoc Health position peaked at $11.3M in Q3 2018.
420 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2019.

Based on Engle Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.